YM 020
Latest Information Update: 17 Jul 1998
Price :
$50 *
At a glance
- Originator Yamanouchi
- Class Antiulcers; Gastric antisecretories
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Peptic ulcer
Most Recent Events
- 17 Jul 1998 No-Development-Reported for Peptic ulcer in Japan (Unknown route)
- 23 Mar 1995 New profile
- 23 Mar 1995 Preclinical development for Peptic ulcer in Japan (Unknown route)